Holen Sie sich die Stockscreener-App
2.305
1.10%
0.025
Vorhandelsmarkt:
2.31
0.005
+0.22%
Schlusskurs vom Vortag:
$2.28
Offen:
$2.25
24-Stunden-Volumen:
516.08K
Relative Volume:
0.83
Marktkapitalisierung:
$278.47M
Einnahmen:
$34.16M
Nettoeinkommen (Verlust:
$-50.62M
KGV:
-4.5374
EPS:
-0.508
Netto-Cashflow:
$703.00K
1W Leistung:
-5.14%
1M Leistung:
-33.76%
6M Leistung:
-43.37%
1J Leistung:
-56.34%
1-Tages-Spanne:
$2.25
$2.31
1-Wochen-Bereich:
$2.25
$2.4701
52-Wochen-Spanne:
$2.2308
$5.5429
Omniab Inc Stock (OABI) Company Profile
Firmenname
Omniab Inc
Sektor
Branche
Telefon
510-250-7800
Adresse
5980 HORTON STREET, EMERYVILLE
Vergleichen Sie OABI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
2.305 | 278.47M | 34.16M | -50.62M | 703.00K | -0.508 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.49 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
625.60 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
583.62 | 35.60B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.83 | 34.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
274.78 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-04-21 | Eingeleitet | The Benchmark Company | Buy |
| 2023-04-13 | Eingeleitet | Craig Hallum | Buy |
| 2023-02-22 | Eingeleitet | Cowen | Outperform |
| 2023-02-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-12-20 | Eingeleitet | Truist | Buy |
| 2022-12-16 | Eingeleitet | Credit Suisse | Outperform |
| 2022-11-29 | Eingeleitet | SVB Leerink | Outperform |
| 2022-11-28 | Eingeleitet | Stifel | Buy |
Alle ansehen
Omniab Inc Aktie (OABI) Neueste Nachrichten
OmniAb CFO Kurt Gustafson sells $28,352 in common stock - Investing.com
OmniAb CFO Kurt Gustafson sells $28,352 in common stock By Investing.com - Investing.com South Africa
OmniAb, Inc. (NASDAQ:OABI) Shares Sold by Swiss National Bank - Defense World
Analyst Forecasts Just Became More Bearish On OmniAb, Inc. (NASDAQ:OABI) - Yahoo
Royal Bank of Canada Lowers OmniAb (NASDAQ:OABI) Price Target to $4.00 - Defense World
Charles Schwab Investment Management Inc. Has $2.90 Million Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
RBC Cuts Price Target on OmniAb to $4 From $7, Keeps Outperform Rating - MarketScreener
Bank of New York Mellon Corp Sells 63,047 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb : March 2025 Corporate Overview -March 24, 2025 at 04:08 pm EDT - Marketscreener.com
OmniAb price target lowered to $4 from $8 at TD Cowen - MSN
Equities Analysts Set Expectations for OmniAb Q1 Earnings - Defense World
Analysts Maintain Strong Buy Rating for OmniAb Stock (OABI) Despite Price Decline - markets.businessinsider.com
OmniAb director John L. Higgins acquires $9,120 in common stock By Investing.com - Investing.com Australia
OmniAb, Inc. (NASDAQ:OABI) Q4 2024 Earnings Call Transcript - Insider Monkey
Benchmark Has Lowered Expectations for OmniAb (NASDAQ:OABI) Stock Price - Defense World
Leerink Partnrs Has Weak Outlook for OmniAb FY2025 Earnings - Defense World
Q4 Earnings Forecast for OmniAb Issued By HC Wainwright - Defense World
Director John Higgins Acquires 125,750 Shares of OmniAb Inc (OAB - GuruFocus
OmniAb’s Earnings Call: Growth Amid Challenges - TipRanks
OmniAb director John L. Higgins acquires $9,120 in common stock - Investing.com
OmniAb’s Strategic Growth and Financial Management Drive Buy Rating - TipRanks
HC Wainwright Reaffirms Buy Rating for OmniAb (NASDAQ:OABI) - Defense World
OmniAb Inc (OABI): At $2.44, It’s Worth Your Attention - Stocks Register
OmniAb director John L. Higgins purchases $295,512 in common stock By Investing.com - Investing.com South Africa
OmniAb director John L. Higgins purchases $295,512 in common stock - Investing.com
Benchmark cuts OmniAb stock price target to $6, maintains Buy By Investing.com - Investing.com Canada
Benchmark cuts OmniAb stock price target to $6, maintains Buy - Investing.com
OmniAb Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
OmniAb shares surge as Q4 revenue more than doubles - Investing.com India
OmniAb Reports 2024 Financial Results and Strategic Growth - TipRanks
Earnings call transcript: OmniAb Q4 2024 sees revenue jump, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: OmniAb Q4 2024 sees revenue jump, stock dips - Investing.com UK
OmniAb, Inc. (OABI) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
OmniAb shares surge as Q4 revenue more than doubles By Investing.com - Investing.com South Africa
OmniAb, Inc. SEC 10-K Report - TradingView
OmniAb Q4 Loss Narrows, Revenue Up; Issues Outlook -March 18, 2025 at 05:02 pm EDT - Marketscreener.com
OmniAb Inc reports results for the quarter ended December 31Earnings Summary - TradingView
OmniAb Inc (OABI) Q4 Earnings: Revenue Beats at $10.8M, EPS Misses at -$0.12 - GuruFocus.com
OMNIAB Earnings Results: $OABI Reports Quarterly Earnings - Nasdaq
OmniAb : 4Q24 Earnings Presentation -March 18, 2025 at 04:19 pm EDT - Marketscreener.com
OmniAb reports Q4 EPS (12c), consensus (10c) - TipRanks
OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights - Business Wire
OmniAb (OABI) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Rhumbline Advisers Sells 19,829 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World
Chiome Bioscience and OmniAb Collaborate on Antibody Research - TipRanks
OmniAb to Report Fourth Quarter 2024 Financial Results on March 18 - Business Wire
OmniAb, Inc. (NASDAQ:OABI) Insider Charles S. Berkman Sells 8,215 Shares - MarketBeat
OmniAb, Inc. (NASDAQ:OABI) CEO Sells $51,387.52 in Stock - MarketBeat
Omniab CFO Kurt Gustafson sells shares worth $26,625 - Investing.com India
Omniab CFO Kurt Gustafson sells shares worth $26,625 By Investing.com - Investing.com Nigeria
OmniAb chief legal officer Charles Berkman sells $56,857 in stock By Investing.com - Investing.com South Africa
Finanzdaten der Omniab Inc-Aktie (OABI)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):